Home/Filings/4/0001179110-18-012086
4//SEC Filing

Parker Katherine 4

Accession 0001179110-18-012086

CIK 0001235007other

Filed

Oct 8, 8:00 PM ET

Accepted

Oct 9, 2:14 PM ET

Size

5.7 KB

Accession

0001179110-18-012086

Insider Transaction Report

Form 4
Period: 2018-10-05
Parker Katherine
VP of Human Resources
Transactions
  • Sale

    Common Stock

    2018-10-05$15.55/sh6,771$105,31670,349 total
Holdings
  • Common Stock

    (indirect: By Trust)
    1,200
Footnotes (1)
  • [F1]Represents the sale of 6,771 shares in multiple transactions ranging in price from $15.1300 to $15.9200, resulting in a weighted-average sale price per share of $15.5540. The 6,771 shares were sold to cover taxes, commissions and fees associated with the October 4, 2018 settlement of 15,000 restricted stock units in the form of Company common stock on a one-for-one basis. The shares were sold pursuant to a written plan as specified in Rule 10b5-1(c) of the Securities Exchange Act of 1934.

Issuer

ENDOCYTE INC

CIK 0001235007

Entity typeother

Related Parties

1
  • filerCIK 0001633299

Filing Metadata

Form type
4
Filed
Oct 8, 8:00 PM ET
Accepted
Oct 9, 2:14 PM ET
Size
5.7 KB